Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of the NQO1 609C>T Polymorphism on Leukemia Susceptibility: Evidence from a Meta-analysis

  • Han, Fei-Fei (Beijing Chao-Yang Hospital Affiliated with Beijing Capital Medical University) ;
  • Guo, Chang-Long (Reproductive and Genetic Center of National Research Institute for Family Planning) ;
  • Gong, Li-Li (Beijing Chao-Yang Hospital Affiliated with Beijing Capital Medical University) ;
  • Jin, Zhu (Beijing Chao-Yang Hospital Affiliated with Beijing Capital Medical University) ;
  • Liu, Li-Hong (Beijing Chao-Yang Hospital Affiliated with Beijing Capital Medical University)
  • Published : 2013.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

A functional polymorphism in the NQO1 gene, featuring a 609C>T substitution,leading to proline to serine amino-acid and enzyme activity changes, has been implicated in cancer risk. However, individually published investigations showed inconclusive results, especially for leukemia. In this study, we therefore performed a meta-analysis of 21 publications with a total of 3,634 cases and 4,827controls, mainly for leukemia. We summarized the data on the association between the NQO1 609C>T polymorphism and risk of leukemia and performed subgroup analyses by ethnicity and leukemia type. We found that the variant TT homozygous genotype o was associated with a modestly increased risk of leukemia (TT versus CT/CC: OR=1.23, 95%CI=1.00-1.51, heterogeneity=0.76; $I^2$=0%). Following further stratified analyses, increased risk was only observed in subgroups of Caucasians. This meta-analysis suggests that the NQO1 609T allele is a high-penetrance risk factor for leukemia in Caucasians. The effect on leukemia may be modified by ethnicity and leukemia type, and the small sample sizes of the subgroup analyses suggest that further larger studies are needed.

Keywords

References

  1. Asher G, Shaul Y (2005). p53 proteasomal degradation: polyubiquitination is not the whole story. Cell Cycle, 4, 1015-8. https://doi.org/10.4161/cc.4.8.1900
  2. Begleiter A, Hewitt D, Gibson SB, et al (2009). Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia. Leuk Res, 33, 74-81. https://doi.org/10.1016/j.leukres.2008.06.030
  3. Bian JT, Zhao HL, Zhang ZX, et al (2008). Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese. J Mol Neurosci, 34, 235-40. https://doi.org/10.1007/s12031-008-9036-z
  4. Bolufer P, Collado M, Barragan E, et al (2007). The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica, 92, 308-14. https://doi.org/10.3324/haematol.10752
  5. Chan JY, Ugrasena DG, et al (2011). Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol, 29, 116-23. https://doi.org/10.1002/hon.965
  6. Clavel J, Bellec S, Rebouissou S, Menegaux F, et al (2005). Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev, 14, 531-40. https://doi.org/10.1097/00008469-200512000-00007
  7. David GL, Romieu I, Sienra-Monge JJ, et al (2003). Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma. Am J Respir Crit Care Med, 168, 1199-204. https://doi.org/10.1164/rccm.200305-684OC
  8. Egger M, Davey Smith G, Schneider M, Minder C (1997).. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  9. Eguchi-Ishimae M, Eguchi M, Ishii E, et al (2005). The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica, 90,1511-5.
  10. Goode EL, White KL, Vierkant RA, et al (2013). Xenobiotic- Metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog, 50, 397-402.
  11. Gra O, Mityaeva O, Berdichevets I, Kozhekbaeva Z, et al (2007). Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians. Genet Test Mol Biomarkers, 14, 329-42.
  12. Guillem VM, Collado M, Terol MJ, et al (2007). Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies. Leukemia, 21, 1413-22. https://doi.org/10.1038/sj.leu.2404709
  13. Iskander K, Jaiswal AK (2005). Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chem Biol Interact, 153-154, 147-57. https://doi.org/10.1016/j.cbi.2005.03.019
  14. Kracht T, Schrappe M, Strehl S, et al (2004). NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica, 89, 1492-7.
  15. Lanciotti M, Dufour C, Corral L, et al (2005). Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia, 19, 214-6. https://doi.org/10.1038/sj.leu.2403613
  16. Li YF, Tseng PJ, Lin CC, et al (2009). NAD(P)H: Quinone oxidoreductase 1, glutathione S-transferase M1, environmental tobacco smoke exposure, and childhood asthma. Mutat Res, 678, 53-8. https://doi.org/10.1016/j.mrgentox.2009.06.008
  17. Lozic B, Primorac D, Glavinic R, et al (2011). Analysis of the C609T polymorphism of NQO1 gene in South Croatian patients with hematological malignancies. Coll Antropol, 35, 385-8.
  18. Malik E, Cohen SB, Sahar D, et al (2006). The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients. Haematologica, 91, 956-9.
  19. Malik MA, Zargar SA, Mittal B (2013). Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. DNA Cell Biol, 30, 297-303.
  20. North M, Tandon VJ, Thomas R, et al (2011). Genome-wide functional profiling reveals genes required for tolerance to benzene metabolites in yeast. PLoS One, 6, e24205. https://doi.org/10.1371/journal.pone.0024205
  21. Pae CU (2008). Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia. Psychiatry Res, 161, 336-8. https://doi.org/10.1016/j.psychres.2006.10.005
  22. Pae CU, Yu HS, Kim JJ, et al (2004). Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int J Neuropsychopharmacol, 7, 495-500. https://doi.org/10.1017/S1461145704004419
  23. Pandith AA, Khan NP, Shah ZA, et al (2011). Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population. Biochem Genet, 49, 417-26. https://doi.org/10.1007/s10528-011-9418-8
  24. Ross D (2005). Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity. Chem Biol Interact, 153-154, 137-46. https://doi.org/10.1016/j.cbi.2005.03.018
  25. Sameer AS, Shah ZA, Syeed N, et al (2010). NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev, 11, 209-13.
  26. SantaCruz KS, Yazlovitskaya E, et al (2004). Regional NAD(P) H:quinone oxidoreductase activity in Alzheimer's disease. Neurobiol Aging, 25, 63-9. https://doi.org/10.1016/S0197-4580(03)00117-9
  27. Sarlauskas J, Nemeikaite-Ceniene A, Anusevicius Z, et al (2004). Enzymatic redox properties of novel nitrotriazole explosives implications for their toxicity. Z Naturforsch C, 59, 399-404.
  28. Seedhouse C, Bainton R, Lewis M, et al (2002). The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood, 100, 3761-6. https://doi.org/10.1182/blood-2002-04-1152
  29. Siegel D, Anwar A, Winski SL, et al (2001). Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol, 59, 263-8. https://doi.org/10.1124/mol.59.2.263
  30. Silveira Vda S, Canalle R, et al (2010). Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen, 51, 48-56.
  31. Smith MT, Wang Y, Kane E, Rollinson S, et al (2001). Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood, 97, 1422-6. https://doi.org/10.1182/blood.V97.5.1422
  32. Snyder R, Hedli CC (1996). An overview of benzene metabolism. Environ Health Perspect, 104, 1165-71. https://doi.org/10.1289/ehp.961041165
  33. Voso MT, Fabiani E, D'Alo F, Guidi F, et al (2007). Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol, 18, 1523-8. https://doi.org/10.1093/annonc/mdm191
  34. Wiemels JL, Pagnamenta A, Taylor GM, et al (1999). A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res, 59, 4095-9.
  35. Wu YX, Gao YJ, Zhao JC, et al (2004). Preliminary study on polymorphism of GSTM1, CYP2E1 and NQO1 genes and risk factors of children leukemia. Zhonghua Liu Xing Bing Xue Za Zhi, 25, 819.
  36. Yamaguti GG, Lourenco GJ, Costa FF, et al (2009). High risk of 'de novo' acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects. Eur J Haematol, 83, 270-2. https://doi.org/10.1111/j.1600-0609.2009.01272.x
  37. Yamaguti GG, Lourenco GJ, Silveira VS, et al (2010). Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H:quinone oxidoreductase 1 (NQO1)-inherited gene variants. Acta Haematol, 124, 182-4. https://doi.org/10.1159/000320275
  38. Yang FY, Guan QK, et al (2013). NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a metaanalysis based on 21 case-control studies. Eur J Cancer Prev, 21, 432-41.
  39. Yeoh AE, Lu Y, et al (2010). Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res, 34, 276-83. https://doi.org/10.1016/j.leukres.2009.07.003
  40. Yuan W, Xu L, Feng Y, et al (2010). The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 122, 835-42. https://doi.org/10.1007/s10549-009-0722-5
  41. Zhang J, Pu yp, Yin lh, Zhu fy, Guo j (2005). Study on the relationship between genetic polymorphism and susceptibility for adult acute leukemia. Tumor Jul, 25.

Cited by

  1. The NAD(P)H: Quinine Oxidoreductase 1 (NQO1) Gene 609 C>T Polymorphism is Associated with Gastric Cancer Risk: Evidence from a Case-control Study and a Meta-analysis vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2363
  2. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-1869-1
  3. Sickle Cell Anemia Patients in Use of Hydroxyurea: Association between Polymorphisms in Genes Encoding Metabolizing Drug Enzymes and Laboratory Parameters vol.2018, pp.1875-8630, 2018, https://doi.org/10.1155/2018/6105691
  4. Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.” vol.70, pp.4, 2018, https://doi.org/10.1080/01635581.2018.1460674